agilon health (NYSE:AGL) Trading 9% Higher

Shares of agilon health, inc. (NYSE:AGLGet Rating) traded up 9% during mid-day trading on Thursday . The company traded as high as $21.78 and last traded at $21.78. 58,730 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 2,324,653 shares. The stock had previously closed at $19.99.

A number of equities analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft dropped their price target on agilon health from $30.00 to $26.00 in a research note on Tuesday, May 10th. Guggenheim lowered their target price on agilon health from $32.00 to $30.00 in a research report on Tuesday, May 10th. Finally, SVB Leerink lifted their target price on agilon health from $25.00 to $33.00 and gave the company an “outperform” rating in a research report on Thursday, March 31st. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $33.83.

The company has a 50-day moving average price of $19.28 and a 200 day moving average price of $20.99. The firm has a market capitalization of $8.93 billion, a PE ratio of -21.38 and a beta of 2.84. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.67 and a quick ratio of 2.67.

In other news, insider Benjamin Shaker sold 2,706 shares of agilon health stock in a transaction dated Thursday, April 7th. The stock was sold at an average price of $25.01, for a total value of $67,677.06. Following the sale, the insider now directly owns 63,910 shares of the company’s stock, valued at $1,598,389.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Michael L. Smith sold 145,874 shares of agilon health stock in a transaction dated Wednesday, May 25th. The stock was sold at an average price of $19.53, for a total value of $2,848,919.22. Following the completion of the sale, the director now directly owns 4,126 shares in the company, valued at $80,580.78. The disclosure for this sale can be found here. Insiders sold 261,424 shares of company stock worth $5,203,044 over the last 90 days. Company insiders own 3.30% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Capital World Investors increased its stake in agilon health by 1.3% during the first quarter. Capital World Investors now owns 36,322,390 shares of the company’s stock worth $920,773,000 after acquiring an additional 456,437 shares during the last quarter. Wellington Management Group LLP increased its stake in agilon health by 11.0% during the first quarter. Wellington Management Group LLP now owns 18,578,035 shares of the company’s stock worth $470,953,000 after acquiring an additional 1,834,890 shares during the last quarter. Vanguard Group Inc. increased its stake in agilon health by 1.4% during the first quarter. Vanguard Group Inc. now owns 13,235,600 shares of the company’s stock worth $335,522,000 after acquiring an additional 177,239 shares during the last quarter. Capital Research Global Investors increased its stake in agilon health by 18.4% during the first quarter. Capital Research Global Investors now owns 9,867,875 shares of the company’s stock worth $250,151,000 after acquiring an additional 1,536,506 shares during the last quarter. Finally, Rock Springs Capital Management LP increased its stake in agilon health by 1.9% during the first quarter. Rock Springs Capital Management LP now owns 7,640,000 shares of the company’s stock worth $193,674,000 after acquiring an additional 145,000 shares during the last quarter. 96.24% of the stock is currently owned by hedge funds and other institutional investors.

About agilon health (NYSE:AGL)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Further Reading

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.